Astepro nasal spray for early COVID-19
Part of Infections, Lungs & breathing clinical trials.
This trial tests whether Astepro nasal spray can help people with mild or no COVID-19 symptoms recover faster. If you have tested positive and are vaccinated, you may qualify.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have tested positive for COVID-19 (via saliva test or rapid antigen test)
- You have no symptoms or only mild symptoms (like no fever or mild fever, no severe cough)
- You have been vaccinated against COVID-19
- You can provide saliva samples every other day for 10 days and report symptoms
- You are not pregnant, breastfeeding, or planning to become pregnant
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 3 trial tests whether a medicated nasal spray can stop COVID-19 from starting after you’ve been exposed to someone who recently tested positive. You must start very soon after the person became symptomatic, and you’ll be checked for eligibility based on timing and your health history.
This trial tests a nasal spray booster for people who have already had 2-3 doses of COVID-19 inactivated vaccine. It studies if the spray is safe and boosts your immune system. You can join if you are healthy, have not had COVID-19 in the last 3 months, and had your last vaccine dose more than 6 months ago.
This trial looks at how well an antiviral works in the body when started early in people with COVID-19 symptoms. You may be able to join if you’re an otherwise healthy adult with confirmed infection and symptoms for less than 4 days.
This study looks at how your immune system responds to COVID-19 or the flu. It may help researchers understand these infections better, whether you are currently sick or healthy.
This trial tests a new nasal spray COVID-19 booster vaccine. It aims to see if the vaccine is safe and produces a strong immune response when given through the nose and inhaled, in people who have already been vaccinated.
This trial tests whether an essential oil-based preparation is safe and effective for adults with mild to moderate COVID-19. It could be an option if you are not severely ill and are not taking other COVID treatments.
Hear when a new COVID-19 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.